Skip to main content
. 2017 Jun 29;8(6):e104. doi: 10.1038/ctg.2017.29

Figure 2.

Figure 2

(a) Serial model for end-stage liver disease (MELD) scores for the individual patients (solid line: group A; dotted line: group B). (b) Serial changes in mean MELD score at week 1, week 2, week 4 and week 12 in total cases. (c) Serial changes in mean MELD score in patients with baseline MELD score >20.